$2.24
-0.11[-4.68%]
At close: Apr 25
$2.24
0[0.00%]
PreMarket: 4:20PM EDT
Omega Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Omega Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/10/2024 | AM | OMGA | Q1 | -$0.50 | -$0.42 | — | — | $516.00K | $460.00K | — | — | Get Alert |
03/28/2024 | AM | OMGA | Q4 | -$0.64 | -$0.45 | -$0.37 | 17.78% | $735.00K | $570.00K | $989.00K | 73.51% | Get Alert |
11/09/2023 | AM | OMGA | Q3 | -$0.54 | -$0.53 | -$0.40 | 24.53% | $595.00K | $440.00K | $831.00K | 88.86% | Get Alert |
08/03/2023 | PM | OMGA | Q2 | -$0.54 | -$0.51 | -$0.54 | -5.88% | $476.00K | $450.00K | $759.00K | 68.67% | Get Alert |
05/04/2023 | AM | OMGA | Q1 | -$0.42 | -$0.60 | -$0.50 | 16.67% | $268.00K | $260.00K | $516.00K | 98.46% | Get Alert |
03/01/2023 | AM | OMGA | Q4 | -$0.44 | -$0.63 | -$0.64 | -1.59% | $144.00K | $260.00K | $735.00K | 182.69% | Get Alert |
11/08/2022 | AM | OMGA | Q3 | -$0.57 | -$0.62 | -$0.54 | 12.90% | $0.00 | $100.00K | $595.00K | 495.00% | Get Alert |
08/04/2022 | AM | OMGA | Q2 | -$3.36 | -$0.52 | -$0.54 | -3.85% | $0.00 | — | $476.00K | — | Get Alert |
05/04/2022 | PM | OMGA | Q1 | -$3.00 | -$0.57 | -$0.42 | 26.32% | $0.00 | — | $268.00K | — | Get Alert |
03/10/2022 | AM | OMGA | Q4 | -$2.18 | -$0.53 | -$0.44 | 16.98% | — | — | $144.00K | — | Get Alert |
11/10/2021 | AM | OMGA | Q3 | -$1.97 | -$0.48 | -$0.57 | -18.75% | $0.00 | — | $0.00 | — | Get Alert |
09/10/2021 | AM | OMGA | Q2 | -$1.58 | -$1.21 | -$3.36 | -177.69% | — | — | $0.00 | — | Get Alert |
Omega Therapeutics (OMGA) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-0.37, which beat the estimate of $-0.45.
The Actual Revenue was $989K, which beat the estimate of $570K.
Browse earnings estimates, EPS, and revenue on all stocks.